Company: HCTI
Filing Date: 2025-10-14
Form Type: DEF 14C
Source: 0001213900-25-098801
Chunk: 4

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-14
Form: DEF 14C
Chunk 4
---
600,000 | ​(2) |     |                                — |   |     |        100 | % |     |       0.77 | % |
| Suresh Venkatachari                                                    |     |                                       |     |                301 |     |    20,000 | ​(3) |     |                             0.01 | % |     |        100 | % |     |      81.05 | % |

____________ (1)The principal address of the named officers, directors and 5% stockholders of the Company is c/o Healthcare Triangle, Inc., 7901 Stoneridge Drive, Suite 

# 220, Pleasanton, CA 94588. (2)SecureKloud Technologies, Inc. is 60.7% owned by SecureKloud Technologies Limited which is a publicly traded company in India. SecureKloud Technologies, Inc, holds 1,600,000 Series B Preferred Shares that carry no voting rights and may be converted into 64,257 common stocks cumulatively. (3)Suresh Venkatachari holds 20,000 Series A Super Voting Preferred Shares that carry 1,000 votes per Preferred Share.
1 INTERESTS OF CERTAIN PERSONS IN OR OPPOSITION TO MATTERS TO BE ACTED UPON None of the persons who have served as our officers or directors since the beginning of our last fiscal year, or any associates of such persons, have any substantial interest, direct or indirect, in the authorization and approval of the Transaction, other than the interests held by such persons through their respective beneficial ownership of the shares of our capital stock set forth above in the section entitled “Security Ownership of Certain Beneficial Owners and Management.” None of our directors opposed the authorization and approval of the Transaction. VOTE OBTAINED — DELAWARE LAW Section 228 of the DGCL generally provides that any action required to be taken at a meeting of stockholders may be taken without a meeting, without prior notice and without a vote, if a written consent thereto is signed by stockholders having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which all shares entitled to vote thereon were present and voted. Pursuant to the Nasdaq Listing Rules, a majority of the outstanding voting shares of stock entitled to vote thereon is required in order to effectuate the Nasdaq Stockholder Approval. In order to eliminate the costs and management time involved in